Fulcrum Therapeutics, Inc.
Ticker: FULC
| Insider | Title |
|---|---|
| Alan A Musso | Chief Financial Officer |
| Alan Ezekowitz | Director |
| Alex Sapir | See Remarks, Director |
| Bryan Stuart | See Remarks, Director |
| Capital Healthcare Fund Lp Ra | 10% or greater ownership |
| Capital Management, L.p. Ra | 10% or greater ownership |
| Christopher Morabito | Chief Medical Officer |
| Christopher Moxham | Chief Scientific Officer |
| Colin Hill | Director |
| Curtis Gale Oltmans | Chief Legal Officer |
| Esther Rajavelu | Chief Financial Officer |
| Gp Iii, Llc Trv | 10% or greater ownership |
| Greg Tourangeau | Principal Accounting Officer |
| James A Geraghty | Director |
| James J. Collins | Director |
| Judith Dunn | See Remarks |
| Kate Haviland | Director |
| Katina Dorton | Director |
| Kevin P Starr | 10% or greater ownership |
| Mark J Levin | 10% or greater ownership |
| Melvin H. Iii Hayes | Chief Operating Officer |
| Patrick Taylor Horn | Chief Medical Officer |
| Peter G. Thomson | VP Finance Accounting |
| Peter Kolchinsky | 10% or greater ownership |
| Rachel K. King | Director |
| Rajeev M. Shah | 10% or greater ownership |
| Robert I Tepper | 10% or greater ownership |
| Robert J Gould | Director |
| Rock Ventures Gp Iii, L.p. Third | 10% or greater ownership |
| Rock Ventures Iii, L.p. Third | 10% or greater ownership |
| Santiago Arroyo | Chief Medical Officer |
| Sonja Banks | Director |